Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The gonorrhea regimen and dialysis comments are preserved historical GlobalRPh content, not a statement of current guideline recommendations.
Check source scope before reading a dose
Stanford adult Ceftriaxone
Product / population
Adult institutional dosing; not a manufacturer-label replacement.
Renal method
Not specified
Source revision
Antibiotic Subcommittee approved August 2026
Retrieved
2026-09-05
Local review status
Source-read local summary; source-specific recommendations are not automatically interchangeable.
Stanford Antimicrobial Safety and Sustainability Program · Adult institutional dosing; not a manufacturer-label replacement.
Renal method: Not specified in this summary. Source date: Antibiotic Subcommittee approved August 2026 Retrieved: 2026-09-05
Source-read local summary; source-specific recommendations are not automatically interchangeable.
Source-specific regimen
Adult IV: usual 1-2 g daily; endovascular, osteomyelitis or PJI 2 g daily; meningitis or E. faecalis endocarditis 2 g every 12 hours. The table specifies no renal, HD or CRRT change.
ceftriaxone:stanford-ceftriaxone-1 · Source locator: PDF page 3, Ceftriaxone row
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.